Alnylam Pharmaceuticals Inc
XETRA:DUL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alnylam Pharmaceuticals Inc
XETRA:DUL
|
US |
|
B
|
British American Tobacco PLC
OTC:BTAFF
|
UK |
|
C
|
Cheniere Energy Inc
F:CHQ1
|
US |
Intrinsic Value
The intrinsic value for
Alnylam Pharmaceuticals Inc (DUL) under the Base Case is 118.47 EUR.
Compared with the current market price of 110.36 EUR, the stock appears
Undervalued by 7% .
DCF suggests overvaluation, while multiples suggest undervaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Alnylam Pharmaceuticals Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Alnylam Pharmaceuticals Inc
Earnings Waterfall
Alnylam Pharmaceuticals Inc
The intrinsic value for
Alnylam Pharmaceuticals Inc (DUL) under the Base Case is 118.47 EUR.
Compared with the current market price of 110.36 EUR, the stock appears Undervalued by 7% .